ERBB2 and neoplasm: In addition, Figure 4 depicts the predicted tumor growth dynamics in HER2+ and Triple Negative cell lines after the administration of MBQ-167 (perturbed model) at 1 and 10 mg/kg BW dose levels, respectively.